An Open-Label, Fixed Sequence Study to Investigate the Potential for Pharmacokinetic and Pharmacodynamic Interaction Between Single-Dose Metformin and Multiple-Dose Canagliflozin in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 01 May 2015
At a glance
- Drugs Canagliflozin (Primary) ; Metformin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics; Pharmacokinetics
- 24 Feb 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 17 Jan 2011 New trial record